Stock VSTM VERASTEM, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Verastem, Inc.

Equities

VSTM

US92337C2035

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-06-07 pm EDT 		5-day change 1st Jan Change
3.4 USD -6.59% Intraday chart for Verastem, Inc. -14.14% -58.23%
May. 28 RBC Halves Price Target on Verastem to $16 From $32, Maintains Outperform Rating, Speculative Risk Qualifier MT
May. 24 Top Midday Decliners MT
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
VERASTEM, INC. Stock Verastem, Inc.
 86.11M - - - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 125B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 108B
BIONTECH SE Stock BioNTech SE
 24.21B -
ARGENX SE Stock argenx SE
 22.78B -
GENMAB A/S Stock Genmab A/S
 17.96B
  1. Stock Market
  2. Equities
  3. VSTM Stock
  4. Charts Verastem, Inc.
  5. Sector Chart